Alterity Therapeutics-ADRATHE
13F holders, Q2 2026 (June 30)21holders +6
6new positions
0sold out
1famous investor
$5.37avg. 13F price*
At the end of Q2 2026, 21 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, up 6 from Q1 2026. 6 opened new positions and 0 sold out. The largest holders were Twin Lakes Capital Management, LLC ($748K), Morgan Stanley ($339K) and Greenleaf Trust ($333K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $93K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 73,642 shares bought, net +73,642 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Twin Lakes Capital Management, LLC | 0.29% | No change | 139,258 | $748K |
| Morgan Stanley | 0.00% | Add +8.0% | 63,065 | $339K |
| Greenleaf Trust | 0.00% | Add +93.8% | 62,000 | $333K |
| HB Wealth Management, LLC | 0.00% | No change | 58,460 | $314K |
| Citadel Advisors | 0.00% | Add +87.3% | 37,597 | $202K |
| HRT Financial LP | 0.00% | New | 17,292 | $92K |
| BNP Paribas Financial Markets | 0.00% | Add +50.4% | 10,239 | $55K |
| GAMMA Investing LLC | 0.00% | Add +24.4% | 2,309 | $12K |
| Rhumbline Advisers | 0.00% | Add +2.0% | 2,009 | $11K |
| Acadian Asset Management LLC | 0.00% | No change | 1,863 | $10K |
| Providence Capital Advisors, LLC | 0.00% | New | 200 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 68 | $362 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $215 |
| Farther Finance Advisors, LLC | 0.00% | Add +77.3% | 39 | $205 |
| CoreCap Advisors, LLC | 0.00% | No change | 21 | $113 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $32 |
| UBS Group AG | 0.00% | New | 5 | $27 |
| Cranbrook Wealth Management, LLC | 0.00% | New | 1 | $6 |
| Danske Bank A/S | 0.00% | No change | 1 | $5 |
| Citigroup Inc. | 0.00% | New | 1 | $5 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.